{"entity":{"type":"insider","cik":"0001705978","url":"/insider/0001705978","json_url":"/insider/0001705978.json","name":"Downs Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2017-08-16","last":"2024-02-06","span_basis":"filed_date"},"name_variants":[{"name":"Downs Christopher","source":"filing","n_filings":7,"first_seen":"2017-08-16","last_seen":"2024-02-06"}],"transactions":[{"id":2195331,"accession":"0001683168-24-000706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-24-000706","line_url":"/filing/0001683168-24-000706#line-1","is_derivative":false,"issuer_cik":"0001705978","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001705978","owner_cik":"0001705978","owner_name":"Downs Christopher","owner_display_name":"Downs Christopher","owner_url":"/insider/0001705978","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66666.0,"shares_display":"66,666","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":19999.8,"total_display":"19,999.80","total_whole":"20,000","shares_owned_after":103438.0,"shares_owned_after_display":"103,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-06","scope":"insider"},{"id":8130487,"accession":"0001683168-23-006001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-23-006001","line_url":"/filing/0001683168-23-006001#line-1","is_derivative":false,"issuer_cik":"0001705978","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001705978","owner_cik":"0001705978","owner_name":"Downs Christopher","owner_display_name":"Downs Christopher","owner_url":"/insider/0001705978","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27000.0,"shares_display":"27,000","price_per_share":1.2658,"price_display":"1.27","price_state":"stated","total_value":34176.6,"total_display":"34,176.60","total_whole":"34,177","shares_owned_after":36772.0,"shares_owned_after_display":"36,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-22","filed_date":"2023-08-23","scope":"insider"},{"id":7936458,"accession":"0001683168-23-002495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-23-002495","line_url":"/filing/0001683168-23-002495#line-1","is_derivative":false,"issuer_cik":"0001705978","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001705978","owner_cik":"0001705978","owner_name":"Downs Christopher","owner_display_name":"Downs Christopher","owner_url":"/insider/0001705978","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3100.0,"shares_display":"3,100","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":9920.0,"total_display":"9,920.00","total_whole":"9,920","shares_owned_after":9251.0,"shares_owned_after_display":"9,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-18","scope":"insider"},{"id":4647775,"accession":"0001683168-21-006141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-006141","line_url":"/filing/0001683168-21-006141#line-1","is_derivative":false,"issuer_cik":"0001705978","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001705978","owner_cik":"0001705978","owner_name":"Downs Christopher","owner_display_name":"Downs Christopher","owner_url":"/insider/0001705978","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.9403,"price_display":"0.94","price_state":"stated","total_value":4701.5,"total_display":"4,701.50","total_whole":"4,702","shares_owned_after":151500.0,"shares_owned_after_display":"151,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider"},{"id":4911846,"accession":"0001683168-21-005869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-005869","line_url":"/filing/0001683168-21-005869#line-1","is_derivative":false,"issuer_cik":"0001705978","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001705978","owner_cik":"0001705978","owner_name":"Downs Christopher","owner_display_name":"Downs Christopher","owner_url":"/insider/0001705978","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":1.1537,"price_display":"1.15","price_state":"stated","total_value":5191.65,"total_display":"5,191.65","total_whole":"5,192","shares_owned_after":146500.0,"shares_owned_after_display":"146,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-22","scope":"insider"},{"id":2718657,"accession":"0001683168-20-002862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-20-002862","line_url":"/filing/0001683168-20-002862#line-1","is_derivative":false,"issuer_cik":"0001705978","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001705978","owner_cik":"0001705978","owner_name":"Downs Christopher","owner_display_name":"Downs Christopher","owner_url":"/insider/0001705978","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":142000.0,"shares_display":"142,000","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":289680.0,"total_display":"289,680.00","total_whole":"289,680","shares_owned_after":142000.0,"shares_owned_after_display":"142,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-24","filed_date":"2020-08-25","scope":"insider"},{"id":4570291,"accession":"0001014108-17-000135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001014108-17-000135","line_url":"/filing/0001014108-17-000135#line-1","is_derivative":false,"issuer_cik":"0001337013","issuer_name":"InfuSystem Holdings, Inc","issuer_ticker":"INFU","issuer_name_source":null,"issuer_url":"/issuer/0001337013","owner_cik":"0001705978","owner_name":"Downs Christopher","owner_display_name":"Downs Christopher","owner_url":"/insider/0001705978","role":"Officer (CFO (interim)","role_mark":"O","role_mark_label":"Officer (CFO (interim)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO (interim)","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7900.0,"shares_display":"7,900","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":15010.0,"total_display":"15,010.00","total_whole":"15,010","shares_owned_after":28840.0,"shares_owned_after_display":"28,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001729427","name":"CNS Pharmaceuticals, Inc.","url":"/issuer/0001729427","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2020-08-25","last_seen":"2024-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001337013","name":"InfuSystem Holdings, Inc","url":"/issuer/0001337013","role":"Officer (CFO (interim)","n_filings":1,"first_seen":"2017-08-16","last_seen":"2017-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001705978","retrieved_at":"2026-08-25T04:30:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}